Anika Loses Line of Sight on Multi-Year Growth Targets
The company grew in the low-teens for 2021 but the ongoing effects of the pandemic caused Anika to adjust its...
Mar 10, 2022,
Anika Loses Line of Sight on Multi-Year Growth Targets
Medartis Aims for Leadership Position in Extremities
The company grew +25% in 2022 and took its U.S. business to the next level with the acquisition of Nextremity...
Mar 09, 2022,
Additional U.S. Patent Approval for Episurf Medical
The patent relates to the company’s technology for individualized surgical guide instruments for cartilage repair in joints....
Mar 09, 2022,
Treace Mining Bunion Expertise for Further Innovation
The company grew nearly 65% in 2021 and believes its focus on bunion surgery will reveal further opportunities for clinical...
Mar 08, 2022,
VySpine Granted FDA Clearance for LumiVy Lumbar Interbody Fusion
LumiVy Lumbar IBF features lumbar interbody fusion devices made from either PEEK Optima LT1 or PEEK Optima HA-Enhanced....
Mar 08, 2022,
Exactech Launches Humeral Reconstruction Implant in Europe
The Equinoxe Humeral Reconstruction Prosthesis addresses proximal humeral bone loss and reconstruction after tumor resection....
Mar 08, 2022,
CoreLink Gains FDA Clearance for Fusation Cervical Anchors
CoreLink Fusation anchors are additively manufactured and designed for robust fixation and bony attachment in challenging anterior cervical fusions....
Mar 08, 2022,
In2Bones Launches CoLink Vallux Active Bunion Procedure
The multi-directional, no fusion correction is intended to speed and simplify bunion correction surgeries....
Mar 08, 2022,
Osteal Therapeutics Closes $30 Million Series B Financing
Proceeds will support clinical development of Osteal's lead candidate, VT-X7, for periprosthetic joint infection....
Mar 08, 2022,
First Cases with Patient-Specific 3D-Printed Implants from LimaCorporate’s ProMade Center
The facility is intended to create faster and more accessible care for U.S. patients requiring personalized solutions....
Mar 08, 2022,
Loading new posts...
No more posts
